中文 
别名:IPKA; OKRBCI; PKI-alpha; PRKACN1; cAMP-dependent protein kinase inhibitor alpha应用:IHC,ICC
反应种属:Human,Mouse
规格：50μl/100μl
| Description |
|---|
| Extremely potent competitive inhibitor of cAMP-dependent protein kinase activity, this protein interacts with the catalytic subunit of the enzyme after the cAMP-induced dissociation of its regulatory chains.Olsen S.R., Mol. Endocrinol. 5:1246-1256(1991).Knoell R., Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.The MGC Project Team, Genome Res. 14:2121-2127(2004). |
| Specification | |
|---|---|
| Aliases | IPKA; OKRBCI; PKI-alpha; PRKACN1; cAMP-dependent protein kinase inhibitor alpha |
| Entrez GeneID | 5569; |
| Swissprot | P61925 |
| WB Predicted band size | 8kDa |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human,Mouse |
| Immunogen | Synthesized peptide derived from internal of human IPKA. |
| Formulation | Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
| Application | |
|---|---|
| IHC | 1/50-1/100 |
| ICC | 1/100-1/500 |
 |
Immunofluorescence analysis of HeLa cells, using TPD52 antibody P41976. |
 |
Immunohistochemistry analysis of paraffin-embedded human brain tissue, using TPD52 antibody P41976. |
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的，不可用于人类或动物的临床诊断或治疗，非药用，非食用。
暂无评论
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的，不可用于人类或动物的临床诊断或治疗，非药用，非食用。
发表回复